Word

HYB-AND-SEQ

Status

Dead

Status Code

606

Status Date

Monday, November 26, 2018

Serial Number

86500105

Mark Type

4000

Filing Date

Friday, January 9, 2015

Published for Opposition

Tuesday, August 25, 2015

Abandoned Date

Monday, November 26, 2018

Trademark Owner History

NanoString Technologies, Inc. - Owner At Publication

Classifications

1 diagnostic reagents for scientific or research use in the field of cancer; diagnostic reagents for scientific research relating to molecular identification and digital quantification; diagnostic reagent kits comprising primarily diagnostic reagents for scientific or research use in the field of cancer; diagnostic test kits for scientific use comprising reagents, slides, solid matrix materials, microfluidic devices and support documentation, namely, instructional manuals, therefor; diagnostic test kits comprising reagents for scientific research relating to molecular identification and digital quantification; diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; diagnostic reagents for clinical or medical laboratory use, namely, reagents for proteomics, RNA transcription and microRNA expression profiling, small-molecule analysis, single nucleotide polymorphisms analysis, DNA sequencing, detection of polymorphisms in human fluids, detection of copy number variations, and clinical, oncology, and hematology diagnostics; multiparameter quantitative detection and analysis products and technology for research and diagnostics for a variety of uses in the health care and other life science sectors, namely, reagents for scientific or medical research use, diagnostic preparations and reagents for scientific or research uses, namely, RNA transcription profiling, proteomics, clinical diagnostics, environmental monitoring, biosurveillance, agricultural inspection, forensic testing of samples containing microorganisms or human fluids, small-molecule analysis, single nucleotide polymorphisms analysis, and DNA sequencing; test kits, consisting of chemical preparations for scientific purposes, in particular for the detection, diagnosis, progress monitoring and progress prediction of diseases, including inflammations, infections, disorders of the central nervous systems, cardiovascular, neurological, endocrine, autoimmune and genetic disorders and cancers; assays, reagents, enzymes, polymerases, buffers and nucleotides, and kits comprised thereof, all for scientific or research use; multiparameter quantitative detection and analysis products and technology for research and diagnostics for a variety of uses in life science sectors namely, diagnostic reagents for scientific in vitro use in biochemistry, clinical chemistry and microbiology, RNA and microRNA expression transcription profiling, proteomics, clinical diagnostics, environmental monitoring, agricultural inspection, small-molecule analysis, single nucleotide polymorphisms analysis, and DNA sequencing

5 diagnostic reagents for medical use in the field of cancer; diagnostic reagent kits comprising primarily of diagnostic reagents for medical use in the field of cancer; chemical reagents for medical use; diagnostic test kits for medical use comprising primarily reagents, slides, solid matrix materials, microfluidic devices sold as a unit with instructional manuals therefor; medical diagnostic test kits for detecting pathogens, comprising primarily reagents, slides, solid matrix materials, microfluidic devices sold as a unit and instructional manuals therefor; medical diagnostic kits comprising medical diagnostic reagents for use in detecting the presence of analytes in samples and identifying sample type, and equipment, namely, medical diagnostic immuno-assays for screening samples detecting the presence of analytes in samples and identifying sample type, sold as a unit with instructional manuals; replacement parts for medical diagnostic kits for use in detecting the presence of analytes in samples and identifying sample type in the nature of equipment, namely, medical diagnostic immune-assays for screening samples detecting the presence of analytes in samples and identifying sample type; medical diagnostic reagents for RNA transcription and microRNA expression profiling, proteomics, small molecule analysis, single nucleotide polymorphisms analysis, DNA sequencing, detection of polymorphisms in human fluids, detection of copy number variations, and clinical, oncology, and hematology diagnostics; multiparameter quantitative detection and analysis products and technology for research and diagnostics for a variety of uses in the health care namely, medical diagnostic reagents and diagnostic reagents for clinical or medical laboratory use, diagnostic reagents for medical in vitro use in biochemistry, clinical chemistry and microbiology, RNA and microRNA expression transcription profiling, proteomics, clinical diagnostics, environmental monitoring, agricultural inspection, small-molecule analysis, single nucleotide polymorphisms analysis, and DNA sequencing; tests designed to isolate and extract cells for genetic analysis, namely, reagents for medical diagnostic use; medical diagnostic reagents and assays for testing of body fluids; kits consisting primarily of medical diagnostic reagents and assays for testing of body fluids; reagents in the form of cell markers and molecule markers for medical purposes

9 computer-based apparatus for detection and analysis of gene expression for scientific use; computer-based apparatus for scientific research, namely, for collecting, processing, and taking images of data in connection with scientific or medical research, the use of diagnostic preparations and reagents for scientific or research use, RNA transcription and microRNA expression profiling, proteomics, environmental monitoring, agricultural inspection, small-molecule analysis, single nucleotide polymorphisms analysis, DNA sequencing, detection of polymorphisms in human fluids, detection of copy number variations, analysis of functional pathway gene sets, and monitoring of biofuel production, and prognostic, predictive, clinical, oncology, and hematology diagnostics; scientific research equipment for imaging single molecule reporters; scanning microscopes; fluorescent microscopes; laboratory equipment, namely, fluidics stations, hybridisation ovens, cartridges carriers and replacement parts therefor; scientific research instruments to process and analyze the single molecule reporters to manage and obtain information from the single molecule reporters; computer software to acquire, analyze and manage the biologic data generated; computer software for controlling fluidics station and scanner functions, for capturing fluorescent signals, and for extracting and analyzing data; diagnostic test kits for scientific use comprising microscope slides and microfluidic devices in the nature of electronic analyzers for the transport and analysis of fluid samples by using microfluidic and nanofluidic channels formed on or in a substrate; kits for scientific research use, namely, for use in detecting the presence of analytes in samples and identifying sample type comprising laboratory equipment for screening samples, detecting the presence of analytes in samples and identifying sample types, namely, containers, dishes, microscope slides, plastic bags, swabs, test tubes, vials and wipes for collecting, storing and transmitting samples and specimens; downloadable multimedia file containing diagnostic test kits for scientific use comprising microscope slides and microfluidic devices, reports, test results, research material, worksheets and other non-printed documents and publications relating to scientific research

10 clinical and medical diagnostic instruments, namely, nucleic acid sequencers

Trademark Events

Nov 26, 2018

Abandonment Notice Mailed - No Use Statement Filed

Nov 26, 2018

Abandonment - No Use Statement Filed

Apr 5, 2018

Notice Of Approval Of Extension Request E-Mailed

Apr 4, 2018

Extension 5 Granted

Mar 30, 2018

Extension 5 Filed

Mar 30, 2018

Teas Extension Received

Oct 19, 2017

Notice Of Approval Of Extension Request E-Mailed

Oct 17, 2017

Extension 4 Granted

Oct 17, 2017

Extension 4 Filed

Oct 17, 2017

Teas Extension Received

Mar 28, 2017

Notice Of Approval Of Extension Request E-Mailed

Mar 24, 2017

Extension 3 Granted

Mar 24, 2017

Extension 3 Filed

Mar 24, 2017

Teas Extension Received

Nov 8, 2016

Notice Of Approval Of Extension Request E-Mailed

Nov 7, 2016

Extension 2 Granted

Oct 18, 2016

Extension 2 Filed

Nov 3, 2016

Case Assigned To Intent To Use Paralegal

Oct 18, 2016

Teas Extension Received

Apr 20, 2016

Notice Of Approval Of Extension Request E-Mailed

Apr 18, 2016

Extension 1 Granted

Apr 18, 2016

Extension 1 Filed

Apr 18, 2016

Teas Extension Received

Oct 20, 2015

Noa E-Mailed - Sou Required From Applicant

Aug 25, 2015

Official Gazette Publication Confirmation E-Mailed

Aug 25, 2015

Published For Opposition

Aug 5, 2015

Notification Of Notice Of Publication E-Mailed

Jul 17, 2015

Law Office Publication Review Completed

Jul 17, 2015

Assigned To Lie

Jul 1, 2015

Approved For Pub - Principal Register

Jul 1, 2015

Examiner's Amendment Entered

Jul 1, 2015

Notification Of Examiners Amendment E-Mailed

Jul 1, 2015

Examiners Amendment E-Mailed

Jul 1, 2015

Examiners Amendment -Written

Jun 26, 2015

Notification Of Non-Final Action E-Mailed

Jun 26, 2015

Non-Final Action E-Mailed

Jun 26, 2015

Non-Final Action Written

Jun 20, 2015

Teas/Email Correspondence Entered

Jun 19, 2015

Correspondence Received In Law Office

Jun 19, 2015

Teas Response To Office Action Received

Apr 22, 2015

Notification Of Non-Final Action E-Mailed

Apr 22, 2015

Non-Final Action E-Mailed

Apr 22, 2015

Non-Final Action Written

Apr 15, 2015

Assigned To Examiner

Jan 22, 2015

New Application Office Supplied Data Entered In Tram

Jan 13, 2015

New Application Entered In Tram